Know Cancer

or
forgot password
  • cancer clinical trials in madison, WI

  • Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer
    University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr
    Madison, Wisconsin 53792
    Prostate Cancer
    Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Prostate Cancer
    AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
    University of Wisconsin, Blood and Bone Marrow Transplant
    Madison, Wisconsin 53792-5156
    Autologous Stem Cell Transplantation
    A Safety and Efficacy Study in Patients With Gastric Cancer
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Gastric Cancer
    Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Advanced Cancer, Non-Small Cell Lung Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    St.Mary'S Hospital
    Madison, Wisconsin 53715
    Atrial Fibrillation, Atrial Flutter
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Metastatic Renal Cell Carcinoma
    Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adenocarcinoma of the Prostate, Prostate Cancer, Stage I Prostate Cancer, Stage II Prostate Cancer
    Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Malignant Neoplasm, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia
    Pazopanib in Treating Patients With Metastatic Urothelial Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Anterior Urethral Cancer, Posterior Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Leukemia
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lithium for Low-Grade Neuroendocrine Tumors
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Neuroendocrine Tumors
    Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
    University of Wisconsin-Madison, Dept of Dermatology
    Madison, Wisconsin 53715
    Cutaneous T-cell Lymphoma (CTCL),
    Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer
    University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Lung Cancer
    BIBW 2992 (Afatinib) in Head & Neck Cancer
    1200.28.0009 Boehringer Ingelheim Investigational Site
    Madison, Wisconsin
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Sexual Functioning in Endometrial Cancer
    University of Wisconsin School of Medicine and Public Health
    Madison, Wisconsin 53792-5666
    Endometrial Cancer, Sexual Function
    R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    UW Health Oncology - 1 South Park
    Extensive Stage Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Metastatic Colorectal Cancer
    Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Metastatic Breast Cancer
    Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Rectal Cancer
    Erlotinib and Sunitinib in NSCLC
    University of Wisconsin Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Non Small Cell Lung Cancer
    Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma
    UWCCC
    Madison, Wisconsin 53792
    Mantle Cell Lymphoma
    Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma
    University of Wisconsin Cancer Center
    Madison, Wisconsin 53792
    Multiple Myeloma
    NM404 as an Imaging Agent in Patients With NSCLC
    University of Wisconsin Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Non Small Cell Lung Cancer
    Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Non Small Cell Lung Cancer
    Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    CNS Brain Metastases, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Esophageal Cancer
    Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Prostate Cancer
    CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer
    University of Wisconsin Hospital & Clinics
    Madison, Wisconsin 53792
    Rectal Cancer
    Pilot Study of 18F-FLT PET
    University of Wisconsin Hospital and clinis
    Madison, Wisconsin 53792
    CNS Brain Metastasis, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Esophageal Cancer
    Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Lung Cancer
    Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma
    University of Wisconsin Hospitals and Clinics
    Madison, Wisconsin 53792
    Melanoma
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840011
    Madison, Wisconsin 53792
    Urinary Bladder Neoplasms
    A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
    Site Reference ID/Investigator# 6653
    Madison, Wisconsin 53792
    Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Neoplasm Metastasis, Nervous System Neoplasms
    Phase 1 Study of MKC-1 in Patients With Advanced Cancer
    U. of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Advanced Cancer
    Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer
    R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
    GSK Clinical Trials Call Center
    Madison, Wisconsin 53792
    Papillomavirus Infections
    A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
    University of Wisconsin-Madison
    Madison, Wisconsin 53792
    Solid Tumors, Hematologic Malignancies, Myelodysplastic Syndrome
    Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
    Investigational Site Number
    Madison, Wisconsin 53792-6164
    Cancer, Non-Small Cell Lung Cancer, Endometrial Carcinoma, Ovarian Carcinoma
    ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Brain and Central Nervous System Tumors
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Pharmaseek, LLC
    Madison, Wisconsin 53717
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Pharmaseek, LLC
    Madison, Wisconsin 53717
    Ulcerative Colitis
    BN83495 in Prostate Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Prostate Cancer
    Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) (The STAR Study)
    University of Wisconsin at Madison
    Madison, Wisconsin 53792
    Thrombotic Thrombocytopenic Purpura
    A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Prostate Cancer
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Endometrial Cancer
    A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Metastatic Solid Tumors
    A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
    Dept of Hematology/Oncology, University of Wisconsin- Madison
    Madison, Wisconsin 53792-5156
    Mantle Cell Lymphoma
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Dean Hematology and Oncology Clinic
    Saint Nicholas Hospital
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Breast Cancer
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of 9cUAB30 in Healthy Participants
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Healthy, no Evidence of Disease
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Head and Neck Cancer
    A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Pain, Fatigue, Sleep Disturbance, Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    Dean Hematology and Oncology Clinic
    Madison, Wisconsin 53717
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Study of Panobinostat in Patients With Neuroendocrine Tumors
    University of Wisconsin, Madison
    Madison, Wisconsin 53792
    Neuroendocrine Tumors
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    UW Health Oncology - 1 South Park
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Trial of LBH589 in Metastatic Thyroid Cancer
    University of Wisconsin - Madison
    Madison, Wisconsin 53792
    Thyroid Carcinoma
    Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
    University of WisconsinPediatric Hematology/Oncology Department
    Madison, Wisconsin 53705-2275
    Recurrent or Refractory Pediatric Ependymoma
    Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
    University of Wisconsin-Madison
    Madison, Wisconsin 53792
    Cervical Cancer